<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36982587</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>14</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Intracellular Conformation of Amyotrophic Lateral Sclerosis-Causative TDP-43.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5513</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24065513</ELocationID><Abstract><AbstractText>Transactive response element DNA/RNA-binding protein 43 kDa (TDP-43) is the causative protein of amyotrophic lateral sclerosis (ALS); several ALS-associated mutants of TDP-43 have been identified. TDP-43 has several domains: an N-terminal domain, two RNA/DNA-recognition motifs, and a C-terminal intrinsically disordered region (IDR). Its structures have been partially determined, but the whole structure remains elusive. In this study, we investigate the possible end-to-end distance between the N- and C-termini of TDP-43, its alterations due to ALS-associated mutations in the IDR, and its apparent molecular shape in live cells using F&#xf6;rster resonance energy transfer (FRET) and fluorescence correlation spectroscopy (FCS). Furthermore, the interaction between ALS-associated TDP-43 and heteronuclear ribonucleoprotein A1 (hnRNP A1) is slightly stronger than that of wild-type TDP-43. Our findings provide insights into the structure of wild-type and ALS-associated mutants of TDP-43 in a cell.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kitamura</LastName><ForeName>Akira</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8357-8593</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Cell Dynamics, Faculty of Advanced Life Science, Hokkaido University, Sapporo 001-0021, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PRIME, The Japan Agency for Medical Research and Development, Tokyo 100-0004, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuno</LastName><ForeName>Sachiko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Cell Dynamics, Graduate School of Life Science, Hokkaido University, Sapporo 001-0021, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawamura</LastName><ForeName>Rintaro</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Cell Dynamics, Graduate School of Life Science, Hokkaido University, Sapporo 001-0021, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinjo</LastName><ForeName>Masataka</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8889-8369</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Cell Dynamics, Faculty of Advanced Life Science, Hokkaido University, Sapporo 001-0021, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JP22gm6410028</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP22ym0126814</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>22H04826, 18K06201, 16KK0156, 22H02578, and 22K19886</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008968" MajorTopicYN="N">Molecular Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">F&#xf6;rster resonance energy transfer</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">fluorescence correlation spectroscopy</Keyword><Keyword MajorTopicYN="N">protein structure</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36982587</ArticleId><ArticleId IdType="pmc">PMC10056606</ArticleId><ArticleId IdType="doi">10.3390/ijms24065513</ArticleId><ArticleId IdType="pii">ijms24065513</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Jones A., Troakes C., King A., Al-Sarraj S., van den Berg L.H. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol. 2012;124:339&#x2013;352. doi: 10.1007/s00401-012-1022-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1022-4</ArticleId><ArticleId IdType="pubmed">22903397</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Cleveland D.W. TDP-43 and FUS/TLS: Emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010;19:R46&#x2013;R64. doi: 10.1093/hmg/ddq137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq137</ArticleId><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A., Bharathi V., Sivalingam V., Girdhar A., Patel B.K. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2019;12:25. doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziortzouda P., Van Den Bosch L., Hirth F. Triad of TDP43 control in neurodegeneration: Autoregulation, localization and aggregation. Nat. Rev. Neurosci. 2021;22:197&#x2013;208. doi: 10.1038/s41583-021-00431-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-021-00431-1</ArticleId><ArticleId IdType="pubmed">33654312</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthouis J., Lu Y.F., Wang Q., Krueger B.J., et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436&#x2013;1441. doi: 10.1126/science.aaa3650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshaies J.E., Shkreta L., Moszczynski A.J., Sidibe H., Semmler S., Fouillen A., Bennett E.R., Bekenstein U., Destroismaisons L., Toutant J., et al. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis. Brain A J. Neurol. 2018;141:1320&#x2013;1333. doi: 10.1093/brain/awy062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy062</ArticleId><ArticleId IdType="pmc">PMC5917749</ArticleId><ArticleId IdType="pubmed">29562314</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S., Cleveland D.W. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr. Opin. Neurobiol. 2011;21:904&#x2013;919. doi: 10.1016/j.conb.2011.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2011.05.029</ArticleId><ArticleId IdType="pmc">PMC3228892</ArticleId><ArticleId IdType="pubmed">21813273</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.C., Sun E., Wancewicz E., Mazur C., et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011;14:459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey J.R., Curk T., Rogelj B., Briese M., Cereda M., Kayikci M., Konig J., Hortobagyi T., Nishimura A.L., Zupunski V., et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 2011;14:452&#x2013;458. doi: 10.1038/nn.2778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2778</ArticleId><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Babinchak W.M., Surewicz W.K. Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43. Nat. Commun. 2021;12:1620. doi: 10.1038/s41467-021-21912-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21912-y</ArticleId><ArticleId IdType="pmc">PMC7955110</ArticleId><ArticleId IdType="pubmed">33712624</ArticleId></ArticleIdList></Reference><Reference><Citation>Francois-Moutal L., Perez-Miller S., Scott D.D., Miranda V.G., Mollasalehi N., Khanna M. Structural Insights Into TDP-43 and Effects of Post-translational Modifications. Front. Mol. Neurosci. 2019;12:301. doi: 10.3389/fnmol.2019.00301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00301</ArticleId><ArticleId IdType="pmc">PMC6934062</ArticleId><ArticleId IdType="pubmed">31920533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiguro T., Sato N., Ueyama M., Fujikake N., Sellier C., Kanegami A., Tokuda E., Zamiri B., Gall-Duncan T., Mirceta M., et al. Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31. Neuron. 2017;94:108&#x2013;124 e7. doi: 10.1016/j.neuron.2017.02.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.02.046</ArticleId><ArticleId IdType="pmc">PMC5681996</ArticleId><ArticleId IdType="pubmed">28343865</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura A., Shibasaki A., Takeda K., Suno R., Kinjo M. Analysis of the substrate recognition state of TDP-43 to single-stranded DNA using fluorescence correlation spectroscopy. Biochem. Biophys. Rep. 2018;14:58&#x2013;63. doi: 10.1016/j.bbrep.2018.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrep.2018.03.009</ArticleId><ArticleId IdType="pmc">PMC5986658</ArticleId><ArticleId IdType="pubmed">29872735</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L.L., Zhao J., Yin X.F., He W.T., Yang H., Che M.X., Hu H.Y. Two mutations G335D and Q343R within the amyloidogenic core region of TDP-43 influence its aggregation and inclusion formation. Sci. Rep. 2016;6:23928. doi: 10.1038/srep23928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23928</ArticleId><ArticleId IdType="pmc">PMC4814915</ArticleId><ArticleId IdType="pubmed">27030292</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakowicz J.R. Principles of Fluorescence Spectroscopy. 3rd ed. Springer; New York, NY, USA: 2006. p. xxvi.954p</Citation></Reference><Reference><Citation>Kim H., Baek I.Y., Seong J. Genetically encoded fluorescent biosensors for GPCR research. Front. Cell Dev. Biol. 2022;10:1007893. doi: 10.3389/fcell.2022.1007893.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.1007893</ArticleId><ArticleId IdType="pmc">PMC9559200</ArticleId><ArticleId IdType="pubmed">36247000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostyuk A.I., Demidovich A.D., Kotova D.A., Belousov V.V., Bilan D.S. Circularly Permuted Fluorescent Protein-Based Indicators: History, Principles, and Classification. Int. J. Mol. Sci. 2019;20:4200. doi: 10.3390/ijms20174200.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20174200</ArticleId><ArticleId IdType="pmc">PMC6747460</ArticleId><ArticleId IdType="pubmed">31461959</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai T., Yamada S., Tominaga T., Ichikawa M., Miyawaki A. Expanded dynamic range of fluorescent indicators for Ca(2+) by circularly permuted yellow fluorescent proteins. Proc. Natl. Acad. Sci. USA. 2004;101:10554&#x2013;10559. doi: 10.1073/pnas.0400417101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0400417101</ArticleId><ArticleId IdType="pmc">PMC490022</ArticleId><ArticleId IdType="pubmed">15247428</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura A., Inada N., Kubota H., Matsumoto G., Kinjo M., Morimoto R.I., Nagata K. Dysregulation of the proteasome increases the toxicity of ALS-linked mutant SOD1. Genes Cells Devoted Mol. Cell. Mech. 2014;19:209&#x2013;224. doi: 10.1111/gtc.12125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12125</ArticleId><ArticleId IdType="pmc">PMC4207061</ArticleId><ArticleId IdType="pubmed">24450587</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.A., Heinze K.G., Schwille P. Fluorescence correlation spectroscopy in living cells. Nat. Methods. 2007;4:963&#x2013;973. doi: 10.1038/nmeth1104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth1104</ArticleId><ArticleId IdType="pubmed">17971781</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura A., Nakayama Y., Shibasaki A., Taki A., Yuno S., Takeda K., Yahara M., Tanabe N., Kinjo M. Interaction of RNA with a C-terminal fragment of the amyotrophic lateral sclerosis-associated TDP43 reduces cytotoxicity. Sci. Rep. 2016;6:19230. doi: 10.1038/srep19230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep19230</ArticleId><ArticleId IdType="pmc">PMC4725827</ArticleId><ArticleId IdType="pubmed">26757674</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura A., Kinjo M. State-of-the-Art Fluorescence Fluctuation-Based Spectroscopic Techniques for the Study of Protein Aggregation. Int. J. Mol. Sci. 2018;19:964. doi: 10.3390/ijms19040964.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19040964</ArticleId><ArticleId IdType="pmc">PMC5979297</ArticleId><ArticleId IdType="pubmed">29570669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacia K., Kim S.A., Schwille P. Fluorescence cross-correlation spectroscopy in living cells. Nat. Methods. 2006;3:83&#x2013;89. doi: 10.1038/nmeth822.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth822</ArticleId><ArticleId IdType="pubmed">16432516</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F., Lu S., Yu H., Chen C., Melamed Z., Guo L., Shorter J., Da Cruz S., Cleveland D.W. Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death. Neuron. 2019;102:339&#x2013;357 e7. doi: 10.1016/j.neuron.2019.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.038</ArticleId><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Duan Y., Duan G., Wang Q., Zhang K., Deng X., Qian B., Gu J., Ma Z., Zhang S., et al. Stress Induces Dynamic, Cytotoxicity-Antagonizing TDP-43 Nuclear Bodies via Paraspeckle LncRNA NEAT1-Mediated Liquid-Liquid Phase Separation. Mol. Cell. 2020;79:443&#x2013;458 e7. doi: 10.1016/j.molcel.2020.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.06.019</ArticleId><ArticleId IdType="pubmed">32649883</ArticleId></ArticleIdList></Reference><Reference><Citation>Evers T.H., van Dongen E.M., Faesen A.C., Meijer E.W., Merkx M. Quantitative understanding of the energy transfer between fluorescent proteins connected via flexible peptide linkers. Biochemistry. 2006;45:13183&#x2013;13192. doi: 10.1021/bi061288t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi061288t</ArticleId><ArticleId IdType="pubmed">17073440</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson G.H., Piston D.W., Barisas B.G. Forster distances between green fluorescent protein pairs. Anal. Biochem. 2000;284:438&#x2013;440. doi: 10.1006/abio.2000.4708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abio.2000.4708</ArticleId><ArticleId IdType="pubmed">10964438</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukavsky P.J., Daujotyte D., Tollervey J.R., Ule J., Stuani C., Buratti E., Baralle F.E., Damberger F.F., Allain F.H. Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat. Struct. Mol. Biol. 2013;20:1443&#x2013;1449. doi: 10.1038/nsmb.2698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2698</ArticleId><ArticleId IdType="pubmed">24240615</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L.L., Xue W., Hong J.Y., Zhang J.T., Li M.J., Yu S.N., He J.H., Hu H.Y. The N-terminal dimerization is required for TDP-43 splicing activity. Sci. Rep. 2017;7:6196. doi: 10.1038/s41598-017-06263-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-06263-3</ArticleId><ArticleId IdType="pmc">PMC5522446</ArticleId><ArticleId IdType="pubmed">28733604</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A., Conicella A.E., Schmidt H.B., Martin E.W., Rhoads S.N., Reeb A.N., Nourse A., Ramirez Montero D., Ryan V.H., Rohatgi R., et al. A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J. 2018;37:e97452. doi: 10.15252/embj.201797452.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797452</ArticleId><ArticleId IdType="pmc">PMC5830921</ArticleId><ArticleId IdType="pubmed">29438978</ArticleId></ArticleIdList></Reference><Reference><Citation>Rekas A., Alattia J.R., Nagai T., Miyawaki A., Ikura M. Crystal structure of venus, a yellow fluorescent protein with improved maturation and reduced environmental sensitivity. J. Biol. Chem. 2002;277:50573&#x2013;50578. doi: 10.1074/jbc.M209524200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M209524200</ArticleId><ArticleId IdType="pubmed">12370172</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai H.W., Henderson J.N., Remington S.J., Campbell R.E. Directed evolution of a monomeric, bright and photostable version of Clavularia cyan fluorescent protein: Structural characterization and applications in fluorescence imaging. Biochem. J. 2006;400:531&#x2013;540. doi: 10.1042/BJ20060874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20060874</ArticleId><ArticleId IdType="pmc">PMC1698604</ArticleId><ArticleId IdType="pubmed">16859491</ArticleId></ArticleIdList></Reference><Reference><Citation>Asakawa K., Handa H., Kawakami K. Optogenetic modulation of TDP-43 oligomerization accelerates ALS-related pathologies in the spinal motor neurons. Nat. Commun. 2020;11:1004. doi: 10.1038/s41467-020-14815-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-14815-x</ArticleId><ArticleId IdType="pmc">PMC7035286</ArticleId><ArticleId IdType="pubmed">32081878</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt H.B., Barreau A., Rohatgi R. Phase separation-deficient TDP43 remains functional in splicing. Nat. Commun. 2019;10:4890. doi: 10.1038/s41467-019-12740-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12740-2</ArticleId><ArticleId IdType="pmc">PMC6814767</ArticleId><ArticleId IdType="pubmed">31653829</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Brindisi A., Giombi M., Tisminetzky S., Ayala Y.M., Baralle F.E. TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: An important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem. 2005;280:37572&#x2013;37584. doi: 10.1074/jbc.M505557200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M505557200</ArticleId><ArticleId IdType="pubmed">16157593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura A., Fujimoto A., Kawashima R., Lyu Y., Moriya K., Kurata A., Takahashi K., Brielmann R., Bott L.C., Morimoto R.I., et al. Hetero-oligomerization of TDP-43 carboxy-terminal fragments with cellular proteins contributes to proteotoxicity. bioRxiv. 2022 doi: 10.1101/2022.05.22.493003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.22.493003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura A., Kubota H., Pack C.G., Matsumoto G., Hirayama S., Takahashi Y., Kimura H., Kinjo M., Morimoto R.I., Nagata K. Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nat. Cell Biol. 2006;8:1163&#x2013;1170. doi: 10.1038/ncb1478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1478</ArticleId><ArticleId IdType="pubmed">16980958</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>